Latham Named IP Transactions Firm of the Year

Managing IP

April 15, 2021

Latham has been named the IP Transactions Firm of the Year by Managing IP for standing out amongst its peers as a part of their 2021 Annual Awards program. Managing IP’s awards are “presented to firms, individuals and companies behind the most innovative and challenging IP work of the past year.”

At the digital awards ceremony, Latham was described as “one of the go-to departments for technology deals” and praised for its “numerous representations in the life sciences sector.” In particular, the firm was recognized for representing Astellas Pharma in its partnership with Adaptimmune to co-develop and co-commercialize stem-cell derived allogenic CAR-T and TCR T-Cell therapies for cancer treatment as well as its role in several collaborations in response to the COVID-19 pandemic.

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.